Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
Pedigree Analysis01:35

Pedigree Analysis

78.7K
Overview
78.7K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

189
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189
Genetic Lingo01:11

Genetic Lingo

84.2K
Overview
84.2K
Epistasis Analysis01:09

Epistasis Analysis

4.9K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
4.9K
Incomplete Dominance01:43

Incomplete Dominance

18.8K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
18.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A bench test analysis of semiology of flow signals from built-in software used in home NIV monitoring.

Scientific reports·2026
Same author

Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly).

European journal of neurology·2026
Same author

Variations in long-term home noninvasive ventilation practices for COPD across Europe: a clinician survey.

ERJ open research·2026
Same author

Liver Gene Therapy in Fabry Disease Mice With Low Doses of rAAV2/8 Expressing a Codon-Optimized hGLA cDNA Results in Long-Term Disease Correction.

Journal of inherited metabolic disease·2026
Same author

Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric Cohort.

Cancer medicine·2026
Same author

Organization and delivery of home-based care for chronic obstructive pulmonary disease patients receiving long-term home non-invasive ventilation: a systematic review.

European journal of internal medicine·2026

Related Experiment Video

Updated: Apr 26, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

7.6K

Genotype-phenotype correlation in Pompe disease, a step forward.

Paola De Filippi1, Kolsoum Saeidi, Sabrina Ravaglia

  • 1Department of Molecular Medicine, University of Pavia, Pavia, Italy. paola.defilippi@unipv.it.

Orphanet Journal of Rare Diseases
|August 9, 2014
PubMed
Summary

Genetic factors like ACE and ACTN3 polymorphisms influence Pompe disease (GAA) progression. Specific genotypes are linked to earlier onset and muscle pain, impacting clinical variability in this rare genetic disorder.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

7.9K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

8.9K

Related Experiment Videos

Last Updated: Apr 26, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

7.6K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

7.9K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

8.9K

Area of Science:

  • Genetics
  • Neuromuscular Disorders
  • Metabolic Diseases

Background:

  • Pompe disease, a progressive myopathy, stems from mutations in the acid alpha-glucosidase (GAA) gene.
  • Significant clinical variability exists among patients, even those with identical GAA mutations or within the same family.

Purpose of the Study:

  • To investigate the influence of genetic polymorphisms on the clinical presentation of Pompe disease.
  • To identify genetic factors that modulate disease onset, severity, and specific symptoms.

Main Methods:

  • Collected clinical data from Pompe disease (GSDII) patients, including age of onset, muscle pain, Walton score, 6-minute walk test, vital capacity, and creatine kinase levels.
  • Analyzed DNA for GAA mutations and polymorphisms in ACE, ACTN3, AGT, and PPARα genes.
  • Compared polymorphisms in patient groups with homogeneous genotypes.

Main Results:

  • Identified patient subgroups with homogeneous genotypes and categorized mutations as "very severe" or "potentially less severe".
  • Observed significant differences in disease-free survival between groups.
  • Found that DD genotype in ACE and XX genotype in ACTN3 were significantly associated with earlier disease onset.
  • The ACE DD genotype also correlated with the presence of muscle pain.

Conclusions:

  • ACE and ACTN3 polymorphisms are identified as genetic factors that modulate the clinical phenotype in Pompe disease patients.
  • These findings contribute to understanding the genetic basis of Pompe disease variability.